Ohcanbohtosat - Relecom, Allan

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity Dahkki Relecom, Allan, Merhi, Maysaloun, Inchakalody, Varghese, Uddin, Shahab, Rinchai, Darawan, Bedognetti, Davide, Dermime, Said

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Screening Status as a Determinant of Choice of Colorectal Cancer Screening Method: A Population-Based Informed Survey Dahkki Sandoval, José Luis, Relecom, Allan, Ducros, Cyril, Bulliard, Jean-Luc, Arzel, Beatrice, Guessous, Idris

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy Dahkki Raza, Afsheen, Merhi, Maysaloun, Inchakalody, Varghese Philipose, Krishnankutty, Roopesh, Relecom, Allan, Uddin, Shahab, Dermime, Said

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Resources-Stratified Guidelines for Classical Hodgkin Lymphoma Dahkki Relecom, Allan, Federico, Massimo, Connors, Joseph M., Coiffier, Bertrand, Biasoli, Irene, Moccia, Alden, Salles, Gilles, McKee, Thomas, Miralbell, Raymond, Borchmann, Peter, Kuruvilla, John, Johnson, Peter, Cavalli, Franco, Delavy, Martine, Dietrich, Pierre-Yves, Flahault, Antoine

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta

Persistent anti-NY-ESO-1-specific T cells and expression of differential biomarkers in a patient with metastatic gastric cancer benefiting from combined radioimmunotherapy treatmen... Dahkki Merhi, Maysaloun, Raza, Afsheen, Inchakalody, Varghese Philipose, Siveen, Kodappully S, Kumar, Deepak, Sahir, Fairooz, Mestiri, Sarra, Hydrose, Shereena, Allahverdi, Niloofar, Jalis, Munir, Relecom, Allan, Al Zaidan, Lobna, Hamid, Mohamed Sir Elkhatim, Mostafa, Mai, Gul, Abdul Rehman Zar, Uddin, Shahab, Al Homsi, Mohammed, Dermime, Said

Viečča ollesdeavstta Viečča ollesdeavstta Viečča ollesdeavstta